AUTHOR=Wang Yu , Liu Songtao , Feng Alei , Luo Huan , Hu Jinwei , Wang Kai , Dong Wei TITLE=Identification of a Rare EGFR T790I Mutation in Lung Adenocarcinoma Sensitive to Osimertinib JOURNAL=Frontiers in Oncology VOLUME=11 YEAR=2021 URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.727312 DOI=10.3389/fonc.2021.727312 ISSN=2234-943X ABSTRACT=

Estimated glomerular filtration rate (EGFR)-sensitive mutations are extremely important for targeted treatment strategies in lung cancer. Osimertinib can effectively inhibit the activity of EGFR-sensitive mutations, including the T790M mutation. However, the efficiency of osimertinib for rare mutation types of T790 is unclear. Here, we report the case of a Chinese patient with lung adenocarcinoma (LADC) harboring a T790I mutation who achieved significant benefits from osimertinib treatment.